Skip to content

Cash ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.4×-0.3×
Staar Surgical logo
Staar SurgicalSTAA
2.2×-0.4×
Bausch + Lomb logo
Bausch + LombBLCO
0.2×0.0×
RxSight, Inc. logo
RxSight, Inc.RXST
0.6×-0.6×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.9×+2.0×
IAR
Integra LifeSciencesIART
0.7×+0.4×

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-47.4%
Enterprise value$65.21M-49.0%
P/E2.4×
P/S1.2×-1.1×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on the most recent quarter.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s cash ratio?
LENSAR, Inc. (LNSR) reported cash ratio of 0.7× in Q1 2026.
How has LENSAR, Inc.'s cash ratio changed year-over-year?
LENSAR, Inc.'s cash ratio decreased by 2.4% year-over-year, from 0.7× to 0.7×.
What is the long-term trend for LENSAR, Inc.'s cash ratio?
Over 5 years (2020 to 2025), LENSAR, Inc.'s cash ratio has grown at a -41.8% compound annual growth rate (CAGR), from 4.8× to 0.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.